GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (XAMS:PHARM) » Definitions » Inventories, Finished Goods

Pharming Group (XAMS:PHARM) Inventories, Finished Goods : €0.0 Mil (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Pharming Group Inventories, Finished Goods?

Pharming Group's quarterly finished goods increased from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€16.8 Mil) but then declined from Dec. 2023 (€16.8 Mil) to Mar. 2024 (€0.0 Mil).

Pharming Group's annual finished goods increased from Dec. 2021 (€8.7 Mil) to Dec. 2022 (€11.8 Mil) and increased from Dec. 2022 (€11.8 Mil) to Dec. 2023 (€16.8 Mil).


Pharming Group Inventories, Finished Goods Historical Data

The historical data trend for Pharming Group's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Inventories, Finished Goods Chart

Pharming Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 10.47 8.72 11.76 16.83

Pharming Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 19.29 - 16.83 -

Pharming Group Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Pharming Group (XAMS:PHARM) Business Description

Traded in Other Exchanges
Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.

Pharming Group (XAMS:PHARM) Headlines

No Headlines